DNAJB4 (HLJ1) is an HSP40 family member that has previously been identified as a tumor suppressor gene in lung, colon, and breast cancer patients [46–48], and that has also been specifically identified as a promising therapeutic target and putative biomarker in NSCLC [49]. This evidence concerns the gene DNAJB1 and breast carcinoma.